Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacology and Toxicity of Erwinia Asparaginase (Erwinase?; Crisantaspase; IND 290) Following Allergy to PEG-Asparaginase in Treatment of Children With Acute Lymphoblastic Leukemia (ALL)

NCT00537030 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00537030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00537030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacology and Toxicity of Erwinia Asparaginase (Erwinase?; Crisantaspase; IND 290) Following Allergy to PEG-Asparaginase in Treatment of Children With Acute Lymphoblastic Leukemia (ALL)
Lead sponsor
Children's Oncology Group
Phase
Not applicable
Overall status
Completed
Start date
February 11, 2008
Completion date
Not reported
Enrollment
59 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

adult acute lymphoblastic leukemia, childhood acute lymphoblastic leukemia